StocksFundsScreenerSectorsWatchlists
ZTS

ZTS - Zoetis Inc Stock Price, Fair Value and News

146.51USD-6.60 (-4.31%)Market Closed

Market Summary

ZTS
USD146.51-6.60
Market Closed
-4.31%

ZTS Alerts

  • 2 major insider sales recently.

ZTS Stock Price

View Fullscreen

ZTS RSI Chart

ZTS Valuation

Market Cap

67.1B

Price/Earnings (Trailing)

28.62

Price/Sales (Trailing)

7.85

EV/EBITDA

19.53

Price/Free Cashflow

41.38

ZTS Price/Sales (Trailing)

ZTS Profitability

EBT Margin

34.36%

Return on Equity

46.91%

Return on Assets

16.41%

Free Cashflow Yield

2.42%

ZTS Fundamentals

ZTS Revenue

Revenue (TTM)

8.5B

Rev. Growth (Yr)

8.48%

Rev. Growth (Qtr)

2.88%

ZTS Earnings

Earnings (TTM)

2.3B

Earnings Growth (Yr)

13.88%

Earnings Growth (Qtr)

-11.91%

Breaking Down ZTS Revenue

Last 7 days

-2.3%

Last 30 days

-14.3%

Last 90 days

-22.2%

Trailing 12 Months

-16.0%

How does ZTS drawdown profile look like?

ZTS Financial Health

Current Ratio

3.36

Debt/Equity

1.31

Debt/Cashflow

0.36

ZTS Investor Care

Dividend Yield

1.06%

Dividend/Share (TTM)

1.56

Buy Backs (1Y)

1.19%

Diluted EPS (TTM)

5.07

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20238.1B8.2B8.4B8.5B
20227.9B8.0B8.0B8.1B
20217.0B7.4B7.6B7.8B
20206.3B6.3B6.5B6.7B
20195.9B6.0B6.2B6.3B
20185.4B5.6B5.7B5.8B
20175.0B5.0B5.1B5.3B
20164.8B4.9B4.9B4.9B
20154.8B4.8B4.8B4.8B
20144.6B4.6B4.7B4.8B
20134.4B4.4B4.5B4.6B
20124.3B4.3B4.3B4.3B
20113.7B3.9B4.1B4.2B
20100003.6B
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022


Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Zoetis Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Apr 18, 2024
lagano roxanne
sold
-139,530
151
-923
executive vice president
Mar 18, 2024
lagano roxanne
sold
-319,967
173
-1,846
executive vice president
Mar 11, 2024
reed willie m
sold
-250,265
182
-1,370
-
Feb 21, 2024
norden gregory
gifted
-
-
-2,214
-
Feb 20, 2024
lagano roxanne
sold
-172,878
187
-923
executive vice president
Feb 20, 2024
peck kristin c
acquired
599,170
46.09
13,000
chief executive officer
Feb 20, 2024
peck kristin c
sold
-2,433,640
187
-13,000
chief executive officer
Feb 13, 2024
lagano roxanne
sold
-532,177
186
-2,848
executive vice president
Feb 12, 2024
lagano roxanne
sold
-71,779
197
-363
executive vice president
Feb 10, 2024
reed willie m
acquired
-
-
1,463
-

1–10 of 50

Which funds bought or sold ZTS recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 18, 2024
SJS Investment Consulting Inc.
added
14.29
-83.00
4,062
-%
Apr 18, 2024
Echo45 Advisors LLC
reduced
-1.6
-38,669
208,636
0.15%
Apr 18, 2024
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P.
added
34.89
29,633,000
219,013,000
1.92%
Apr 18, 2024
Piscataqua Savings Bank
new
-
8,460
8,460
0.01%
Apr 18, 2024
Dixon Mitchell Investment Counsel Inc.
new
-
8,799
8,799
-%
Apr 18, 2024
PayPay Securities Corp
added
3.45
-686
5,076
0.25%
Apr 18, 2024
Nvest Financial, LLC
added
6.59
-141,536
1,500,440
1.00%
Apr 18, 2024
Congress Wealth Management LLC / DE /
reduced
-0.48
-2,998,270
17,430,600
0.30%
Apr 18, 2024
Allspring Global Investments Holdings, LLC
reduced
-10.82
-22,776,200
73,972,500
0.12%
Apr 18, 2024
Diversified Trust Co
reduced
-0.95
-146,951
827,267
0.03%

1–10 of 50

Are Funds Buying or Selling ZTS?

Are funds buying ZTS calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own ZTS
No. of Funds

Unveiling Zoetis Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
8.78%
40,332,692
SC 13G/A
Jan 26, 2024
blackrock inc.
7.9%
36,492,748
SC 13G/A
Feb 09, 2023
vanguard group inc
7.91%
36,850,763
SC 13G/A
Feb 06, 2023
blackrock inc.
8.6%
40,082,444
SC 13G/A
Feb 03, 2022
blackrock inc.
8.5%
40,315,810
SC 13G/A
Feb 10, 2021
vanguard group inc
7.79%
37,023,889
SC 13G/A
Feb 01, 2021
blackrock inc.
8.6%
40,720,915
SC 13G/A
Feb 12, 2020
vanguard group inc
7.85%
37,400,083
SC 13G/A
Feb 06, 2020
blackrock inc.
8.7%
41,563,670
SC 13G/A

Recent SEC filings of Zoetis Inc

View All Filings
Date Filed Form Type Document
Apr 18, 2024
4
Insider Trading
Apr 18, 2024
144
Notice of Insider Sale Intent
Apr 16, 2024
8-K
Current Report
Apr 10, 2024
DEFA14A
DEFA14A
Apr 10, 2024
DEF 14A
DEF 14A
Apr 10, 2024
ARS
ARS
Apr 09, 2024
4
Insider Trading
Apr 09, 2024
4
Insider Trading
Apr 09, 2024
4
Insider Trading
Apr 09, 2024
4
Insider Trading

Peers (Alternatives to Zoetis Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
356.3B
85.2B
-5.03% -9.57%
10.14
4.18
6.46% 95.94%
318.7B
60.1B
1.61% 10.23%
873.24
5.3
1.40% -97.49%
146.8B
46.5B
-6.17% -34.78%
-105.7
3.15
42.59% -114.62%
144.1B
28.2B
-1.51% 10.46%
21.46
5.11
7.09% 2.52%
83.2B
27.1B
-9.77% -21.18%
14.68
3.07
-0.60% 23.36%
14.4B
15.8B
-4.60% 54.01%
-25
0.91
6.17% 76.47%
MID-CAP
4.2B
4.7B
-1.63% -14.16%
-328.55
0.9
4.58% 90.97%
4.0B
1.7B
-13.93% -17.76%
11.2
2.4
49.61% 324.78%
3.2B
8.8B
-9.38% 13.00%
-5.36
0.36
7.79% -163.11%
1.9B
644.4M
-9.13% -7.04%
13.99
2.99
29.14% 50.51%
SMALL-CAP
1.3B
743.2M
-12.63% -26.38%
-3.8
1.8
24.65% 80.36%
21.6M
1.3M
-20.43% -49.32%
-2.1
16.56
-98.14% -109.18%
16.6M
-
-10.09% 36.11%
-0.9
0.22
2882.68% -138.52%
2.6M
19.6M
-34.48% -94.22%
-0.18
0.13
80.00% 43.08%
546.5K
117.6M
-96.45% -95.94%
0
0
-0.79% -283.60%

Zoetis Inc News

Latest updates
MarketBeat26 hours ago
Yahoo Canada Finance33 hours ago
Yahoo Finance17 Apr 202411:02 am
Yahoo Finance15 Apr 202410:15 pm
Seeking Alpha12 Apr 202405:25 pm
Simply Wall St12 Apr 202407:00 am

Zoetis Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue2.9%2,2132,1512,1802,0002,0402,0022,0521,9861,9671,9901,9481,8711,8071,7861,5481,5341,6741,5841,5471,4551,564
  S&GA Expenses7.6%565525556505514501529465593504495409520424393389472391406369420
EBITDA Margin-0.3%0.43*0.43*0.43*0.41*0.41*0.41*0.40*0.41*0.41*0.40*0.41*0.41*---------
Interest Expenses0%59.0059.0058.0063.0062.0053.0053.0053.0054.0056.0057.0057.0058.0062.0058.0053.0056.0056.0055.0056.0059.00
Income Taxes5.0%12712120214613213914113393.0010712512962.0011810674.0053.0095.0084.0069.0073.00
Earnings Before Taxes-9.3%650717872697592667670727506659636687420597482497437528455381418
EBT Margin-0.1%0.34*0.34*0.34*0.32*0.33*0.32*0.32*0.32*0.32*0.32*0.32*0.31*---------
Net Income-11.9%525596671552461529529595414552512559359479377423384433371312345
Net Income Margin0.7%0.27*0.27*0.27*0.26*0.26*0.26*0.26*0.26*0.26*0.26*0.26*0.25*---------
Free Cashflow20.7%69957917.00326570372190194511534368323---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets1.3%14,28614,10613,74913,75414,90013,67413,77013,86013,90013,70514,06913,79613,60013,72513,06911,52811,54511,27210,98610,88310,800
  Current Assets1.9%6,3436,2226,1836,2697,5066,5516,6516,8376,9306,6827,0486,7946,6116,7576,2854,7724,7484,6184,4844,3794,399
    Cash Equivalents16.4%2,0411,7541,7172,1093,5812,5072,6523,1353,4853,2743,6583,6023,6043,6543,3531,9511,9341,8151,7551,7281,602
  Inventory-6.6%2,5642,7442,7012,5632,3452,3032,2052,0571,9231,8751,8021,7001,6281,6261,5841,4811,4101,4391,4041,3611,391
  Net PPE3.6%3,2043,0923,0112,9132,7532,6232,5592,4872,4222,3382,2862,2272,2022,0992,0111,9771,9401,8131,7391,6831,658
  Goodwill-0.1%2,7592,7622,7142,7382,7462,6922,7202,6852,6822,7032,7182,7072,6942,6902,6292,5832,5922,5502,5052,5222,519
Liabilities2.9%9,2959,0329,1289,26310,5229,0129,1909,2029,3569,0249,7179,7049,83610,11810,0828,7758,8378,5948,5758,5668,592
  Current Liabilities17.5%1,8891,6081,7691,9153,1672,8803,0513,0341,7971,4712,0912,0662,1702,4001,8111,7211,8061,0521,0751,0821,223
  Short Term Borrowings50.0%3.002.002.003.002.003.002.00---4.004.004.001.001.00-----9.00
  Long Term Debt0.2%6,5646,5526,5556,5596,5525,2105,2215,2286,5926,5926,5926,5876,5956,5957,1945,9635,9476,4476,4466,4446,443
    LT Debt, Current-----1,3501,3501,3501,350--6006006001,100500-500----
    LT Debt, Non Current0.2%6,5646,5526,5556,5596,5525,2105,2215,2286,5926,5926,5926,5876,5956,5957,1945,9635,9476,4476,4466,4446,443
Shareholder's Equity-1.6%4,9975,0784,6214,4914,4054,6624,5804,6584,5444,6814,3524,0923,7733,6072,9872,7532,7082,6782,4112,3172,185
  Retained Earnings1.5%10,29510,1409,5439,0458,6688,5338,0047,6287,1867,0446,4926,0995,6595,5265,0484,7644,4274,2173,7883,4953,270
  Additional Paid-In Capital1.5%1,1331,1161,0981,0791,0881,0731,0591,0461,0681,0561,0441,0301,0651,0401,0301,0171,0441,0311,0191,0081,026
Accumulated Depreciation2.6%2,5942,5292,4472,3742,2972,2322,1932,1412,0722,1132,0642,0121,9521,8941,8181,7691,7371,7251,6851,6421,599
Shares Outstanding-0.3%458460461462464468470472474475475476---------
Minority Interest-50.0%-6.00-4.00-4.00-3.00-2.00-1.00--1.002.002.003.004.005.005.00------
Float---79,346---80,550---88,374---65,094---54,228--
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations23.9%897724183549741526336309679653481400718562438408582506318389584
  Share Based Compensation0%17.0017.0017.009.0016.0015.0015.0016.0014.0015.0016.0013.0013.0014.0016.0016.0016.0016.0017.0018.0029.00
Cashflow From Investing22.5%-210-271-80.00-216-438-124-203-118-142-114-139-63.00-177-174-164-57.00-213-209-59.00-23.00-74.00
Cashflow From Financing4.6%-397-416-494-1,802780-529-610-545-314-919-290-339-597-93.001,141-328-250-232-226-243-197
  Buy Backs-6.0%235250324283405377451361198198166181---250176150150150150

ZTS Income Statement

2023-12-31
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]   
Revenues$ 8,544$ 8,080$ 7,776
Costs and expenses:   
Cost of Sales[1]2,5612,4542,303
Selling, general and administrative expenses[1]2,1512,0092,001
Research and development expenses[1]614539508
Amortization of intangible assets149150161
Total Restructuring charges and certain acquisition-related costs531143
Interest expense, net of capitalized interest239221224
Other (income)/deductions––net(159)4048
Income before provision for taxes on income[2]2,9362,6562,488
Provision for taxes on income596545454
Net income before allocation to noncontrolling interests2,3402,1112,034
Less: Net loss attributable to noncontrolling interests(4)(3)(3)
Net income attributable to Zoetis Inc.$ 2,344$ 2,114$ 2,037
Earnings per share attributable to Zoetis Inc. stockholders:   
Basic (in dollars per share)$ 5.08$ 4.51$ 4.29
Diluted (in dollars per share)$ 5.07$ 4.49$ 4.27
Weighted-average common shares outstanding:   
Basic (in shares)461,172468,891474,348
Diluted (in shares)462,269470,385476,717
Dividends declared per common share$ 1.557$ 1.350$ 1.075
[1]Exclusive of amortization of intangible assets, except as disclosed in Note 3. Significant Accounting Policies—Amortization of Intangible Assets, Depreciation and Certain Long-Lived Assets.
[2]Defined as income before provision for taxes on income.

ZTS Balance Sheet

2023-12-31
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Assets  
Cash and cash equivalents[1]$ 2,041$ 3,581
Accounts receivable, less allowance for doubtful accounts of $18 in 2023 and $19 in 20221,3041,215
Inventories2,5642,345
Other current assets434365
Total current assets6,3437,506
Property, plant and equipment, less accumulated depreciation of $2,594 in 2023 and $2,297 in 20223,2042,753
Operating lease right of use assets230220
Goodwill2,7592,746
Identifiable intangible assets, less accumulated amortization1,3381,380
Noncurrent deferred tax assets206173
Other noncurrent assets206147
Total assets14,28614,925
Liabilities and Equity  
Short-term borrowings32
Current portion of long-term debt01,350
Accounts payable411405
Dividends payable198174
Accrued expenses683682
Accrued compensation and related items382300
Income taxes payable110157
Other current liabilities10297
Total current liabilities1,8893,167
Long-term debt, net of discount and issuance costs6,5646,552
Noncurrent deferred tax liabilities146142
Operating lease liabilities188186
Other taxes payable271258
Other noncurrent liabilities237217
Total liabilities9,29510,522
Common stock, $0.01 par value: 6,000,000,000 authorized, 501,891,243 and 501,891,243 shares issued; 458,367,358 and 463,808,059 shares outstanding at December 31, 2023 and 2022, respectively55
Treasury stock, at cost, 43,523,885 and 38,083,184 shares of common stock at December 31, 2023 and 2022, respectively(5,597)(4,539)
Additional paid-in capital1,1331,088
Retained earnings10,2958,668
Accumulated other comprehensive loss(839)(817)
Stockholders' Equity Attributable to Parent4,9974,405
Stockholders' Equity Attributable to Noncontrolling Interest(6)(2)
Total equity4,9914,403
Total liabilities and equity$ 14,286$ 14,925
[1]As of December 31, 2023 and 2022, includes $2 million and $4 million, respectively, of restricted cash.
ZTS
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products. It markets its products to veterinarians, livestock producers, and pet owners. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
 CEO
 WEBSITEzoetis.com
 INDUSTRYPharmaceuticals
 EMPLOYEES13800

Zoetis Inc Frequently Asked Questions


What is the ticker symbol for Zoetis Inc? What does ZTS stand for in stocks?

ZTS is the stock ticker symbol of Zoetis Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Zoetis Inc (ZTS)?

As of Fri Apr 19 2024, market cap of Zoetis Inc is 67.08 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ZTS stock?

You can check ZTS's fair value in chart for subscribers.

What is the fair value of ZTS stock?

You can check ZTS's fair value in chart for subscribers. The fair value of Zoetis Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Zoetis Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ZTS so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Zoetis Inc a good stock to buy?

The fair value guage provides a quick view whether ZTS is over valued or under valued. Whether Zoetis Inc is cheap or expensive depends on the assumptions which impact Zoetis Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ZTS.

What is Zoetis Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 19 2024, ZTS's PE ratio (Price to Earnings) is 28.62 and Price to Sales (PS) ratio is 7.85. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ZTS PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Zoetis Inc's stock?

In the past 10 years, Zoetis Inc has provided 0.179 (multiply by 100 for percentage) rate of return.